Literature DB >> 22116078

Impact of circulating vaspin levels on metabolic variables in elderly twins.

K Hida, P Poulsen, S Teshigawara, E Nilsson, M Friedrichsen, R Ribel-Madsen, L Grunnet, S S Lund, J Wada, A Vaag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22116078     DOI： 10.1007/s00125-011-2385-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.

Authors:  Kazuyuki Hida; Jun Wada; Jun Eguchi; Hong Zhang; Masako Baba; Aya Seida; Izumi Hashimoto; Tatsuo Okada; Akihiro Yasuhara; Atsuko Nakatsuka; Kenichi Shikata; Shinji Hourai; Junichiro Futami; Eijiro Watanabe; Yasushi Matsuki; Ryuji Hiramatsu; Shigeru Akagi; Hirofumi Makino; Yashpal S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-19       Impact factor: 11.205

2.  Serum vaspin concentrations in human obesity and type 2 diabetes.

Authors:  Byung-Soo Youn; Nora Klöting; Jürgen Kratzsch; Namseok Lee; Ji Woo Park; Eun-Sun Song; Karen Ruschke; Andreas Oberbach; Mathias Fasshauer; Michael Stumvoll; Matthias Blüher
Journal:  Diabetes       Date:  2007-11-08       Impact factor: 9.461

3.  Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.

Authors:  Nese Ersoz Gulcelik; Jale Karakaya; Arzu Gedik; Aydan Usman; Alper Gurlek
Journal:  Eur J Endocrinol       Date:  2008-10-24       Impact factor: 6.664

4.  Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans.

Authors:  Christian von Loeffelholz; Matthias Möhlig; Ayman M Arafat; Frank Isken; Joachim Spranger; Knut Mai; Harpal S Randeva; Andreas F H Pfeiffer; Martin O Weickert
Journal:  Eur J Endocrinol       Date:  2009-12-01       Impact factor: 6.664

5.  Serum levels of the adipokine vaspin in relation to metabolic and renal parameters.

Authors:  Jeannette Seeger; Michaela Ziegelmeier; Anette Bachmann; Ulrike Lössner; Jürgen Kratzsch; Matthias Blüher; Michael Stumvoll; Mathias Fasshauer
Journal:  J Clin Endocrinol Metab       Date:  2007-10-23       Impact factor: 5.958

6.  Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain.

Authors:  K Kawano; T Hirashima; S Mori; Y Saitoh; M Kurosumi; T Natori
Journal:  Diabetes       Date:  1992-11       Impact factor: 9.461

7.  Increased risk of type 2 diabetes in elderly twins.

Authors:  Pernille Poulsen; Louise G Grunnet; Kasper Pilgaard; Heidi Storgaard; Amra Alibegovic; Mette P Sonne; Bendix Carstensen; Henning Beck-Nielsen; Allan Vaag
Journal:  Diabetes       Date:  2009-03-31       Impact factor: 9.461
  7 in total
  9 in total

Review 1.  The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis.

Authors:  Rumyana Dimova; Tsvetalina Tankova
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

2.  Serum vaspin level as a predictive indicator in the amelioration of fatty liver and metabolic disturbance in patients with severe obesity after laparoscopic vertical banded gastroplasty.

Authors:  Yong Wang; Zong-Fan Yu; Yun-Sheng Cheng; Ben-Li Jia; Gang Yu; Xiao-Qiang Yin; Yang Wang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study.

Authors:  Wei Yang; Yun Li; Tian Tian; Li Wang
Journal:  Biomed Res Int       Date:  2017-05-03       Impact factor: 3.411

4.  Correlation of Serum Vaspin, Omentin-1, and adiponectin with metabolic phenotypes in Type-2 diabetes mellitus patients.

Authors:  Mukhtiar Baig; Zohair J Gazzaz; Marwan A Bakarman; Sami H Alzahrani
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

5.  The serum vaspin levels are reduced in Japanese chronic hemodialysis patients.

Authors:  Junko Inoue; Jun Wada; Sanae Teshigawara; Kazuyuki Hida; Atsuko Nakatsuka; Yuji Takatori; Shoichirou Kojo; Shigeru Akagi; Kazushi Nakao; Nobuyuki Miyatake; John F McDonald; Hirofumi Makino
Journal:  BMC Nephrol       Date:  2012-12-03       Impact factor: 2.388

6.  Vaspin inhibits kallikrein 7 by serpin mechanism.

Authors:  John T Heiker; Nora Klöting; Peter Kovacs; E Bartholomeus Kuettner; Norbert Sträter; Stephan Schultz; Matthias Kern; Michael Stumvoll; Matthias Blüher; Annette G Beck-Sickinger
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

7.  Vaspin attenuates the progression of atherosclerosis by inhibiting ER stress-induced macrophage apoptosis in apoE‑/‑ mice.

Authors:  Ying Lin; Jianhui Zhuang; Hailing Li; Guofu Zhu; Shunping Zhou; Weiming Li; Wenhui Peng; Yawei Xu
Journal:  Mol Med Rep       Date:  2015-12-22       Impact factor: 2.952

8.  Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications.

Authors:  Wei Yang; Yun Li; Tian Tian; Li Wang; Pearl Lee; Qi Hua
Journal:  BMC Endocr Disord       Date:  2017-10-24       Impact factor: 2.763

9.  An Electrochemical Aptasensor Platform Based on Flower-Like Gold Microstructure-Modified Screen-Printed Carbon Electrode for Detection of Serpin A12 as a Type 2 Diabetes Biomarker.

Authors:  Armin Salek Maghsoudi; Shokoufeh Hassani; Milad Rezaei Akmal; Mohammad Reza Ganjali; Kayvan Mirnia; Parviz Norouzi; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.